Global law firm Ashurst has advised long-standing client Agilitas Private Equity on the buyout of Frontier Medical Group (‘Frontier’), a leading medical device manufacturer that focuses on skin and wound care.
Frontier has over 24 years’ experience designing and manufacturing clinically proven, high-quality and cost-effective products that are used in the prevention and treatment of pressure ulcers. Frontier supplies both acute and homecare markets in the UK and internationally and maintains its market-leading position through a dedicated in-house Research and Development function.
Frontier operates internationally via its headquarters and manufacturing facility in South Wales, as well as its offices in Berlin and Buffalo, NY. It has direct sales teams in the UK, Germany and the US, and benefits from a network of distributors across 18 countries.
